Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Pamela Kunz
ECOG-ACRIN Cancer Research Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
323 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Kaiser Anaheim Medical Center
Anaheim, California, United States
- Kaiser Permanente-Deer Valley Medical Center
Antioch, California, United States
- Kaiser Permanente Medical Group - Baldwin Park
Baldwin Park, California, United States
- Kaiser Foundation Hospital
Bellflower, California, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Mills - Peninsula Hospitals
Burlingame, California, United States
- Kaiser Permanente Hospital
Fontana, California, United States
- Kaiser Permanente, Fremont
Fremont, California, United States
- Kaiser Permanente
Fresno, California, United States
- Kaiser Permanente - Harbor City
Harbor City, California, United States
- Kaiser Permanente, Hayward
Hayward, California, United States
- Southern California Permanente Medical Group
Irvine, California, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- Kaiser Permanente Los Angeles Medical Center
Los Angeles, California, United States
- Kaiser Permanente-West Los Angeles
Los Angeles, California, United States
- University of Southern California/norris Cancer Center
Los Angeles, California, United States
- Kaiser Permanente-Modesto
Modesto, California, United States
- Sutter Cancer Research Consortium
Novato, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- University of California Medical Center at Irvine-Orange Campus
Orange, California, United States
- Kaiser Permanente - Panorama City
Panorama City, California, United States
- Kaiser Permanente-Redwood City
Redwood City, California, United States
- Kaiser Permanente-Richmond
Richmond, California, United States
- Kaiser Permanente Medical Center
Riverside, California, United States
- Kaiser Permanente-Roseville
Roseville, California, United States
- Kaiser Permanente - Sacramento
Sacramento, California, United States
- Kaiser Permanente-South Sacramento
Sacramento, California, United States
- Kaiser Permanente
San Diego, California, United States
- Kaiser Permanente at San Diego
San Diego, California, United States
- California Pacific Medical Center
San Francisco, California, United States
- Kaiser Permanente-San Francisco
San Francisco, California, United States
- Ucsf-Mount Zion
San Francisco, California, United States
- Kaiser Permanente-Santa Teresa-San Jose
San Jose, California, United States
- Kaiser Permanente Health Care
San Marcos, California, United States
- Kaiser Permanente-San Rafael
San Rafael, California, United States
- Kaiser Permanente Medical Center - Santa Clara
Santa Clara, California, United States
- Kaiser Permanente-Santa Rosa
Santa Rosa, California, United States
- Sutter Pacific Medical Foundation
Santa Rosa, California, United States
- Kaiser Permanente-South San Francisco
South San Francisco, California, United States
- Stanford University Hospitals and Clinics
Stanford, California, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Aug 2013
- Primary completion
- 26 May 2021
- Completion
- 31 Dec 2026
- Last update posted
- 25 Feb 2026
- Registered enrollment
- 144
- Registry id
- NCT01824875
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.